COVID-19 vaccination in individuals with inflammatory rheumatic diseases

Since the start of the SARS-CoV-2 vaccination campaign, our knowledge of the effects of vaccines in people with inflammatory rheumatic diseases has remained incomplete. In particular, the effects of immunomodulatory therapies on vaccine success are poorly understood. Three notable papers from the pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Skapenko, Alla, Schulze-Koops, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Year in Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748886/
https://www.ncbi.nlm.nih.gov/pubmed/36517627
http://dx.doi.org/10.1038/s41584-022-00892-3
Descripción
Sumario:Since the start of the SARS-CoV-2 vaccination campaign, our knowledge of the effects of vaccines in people with inflammatory rheumatic diseases has remained incomplete. In particular, the effects of immunomodulatory therapies on vaccine success are poorly understood. Three notable papers from the past year have helped to fill these knowledge gaps.

Ejemplares similares